CACNB4 Gene
Introduction
Cacnb4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>CACNB4</td></tr>
<tr><th>Full Name</th><td>Calcium Voltage-Gated Channel Auxiliary Subunit Beta 4</td></tr>
<tr><th>Chromosomal Location</th><td>2q22.3</td></tr>
<tr><th>NCBI Gene ID</th><td>785</td></tr>
<tr><th>OMIM</th><td>601949</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000163070</td></tr>
<tr><th>UniProt ID</th><td>O43497</td></tr>
<tr><th>Aliases</th><td>CaB4, CAB4, EA2</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
The CACNB4 gene encodes the beta-4 auxiliary subunit of voltage-gated calcium channels (VGCCs), also known as CaB4 or CACNB4[@ae2000]. Beta-4 is primarily expressed in the brain, particularly in the cerebellum and hippocampus, where it plays critical roles in synaptic transmission, neuronal excitability, and motor coordination[@j2019]. Mutations in CACNB4 are associated with neurological disorders including epilepsy, ataxia, and migraine[@f2010].
The CACNB4 gene is located on chromosome 2q22.3 and encodes a protein of approximately 597 amino acids. Multiple isoforms are generated through alternative splicing:
...
CACNB4 Gene
Introduction
Cacnb4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>CACNB4</td></tr>
<tr><th>Full Name</th><td>Calcium Voltage-Gated Channel Auxiliary Subunit Beta 4</td></tr>
<tr><th>Chromosomal Location</th><td>2q22.3</td></tr>
<tr><th>NCBI Gene ID</th><td>785</td></tr>
<tr><th>OMIM</th><td>601949</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000163070</td></tr>
<tr><th>UniProt ID</th><td>O43497</td></tr>
<tr><th>Aliases</th><td>CaB4, CAB4, EA2</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
The CACNB4 gene encodes the beta-4 auxiliary subunit of voltage-gated calcium channels (VGCCs), also known as CaB4 or CACNB4[@ae2000]. Beta-4 is primarily expressed in the brain, particularly in the cerebellum and hippocampus, where it plays critical roles in synaptic transmission, neuronal excitability, and motor coordination[@j2019]. Mutations in CACNB4 are associated with neurological disorders including epilepsy, ataxia, and migraine[@f2010].
The CACNB4 gene is located on chromosome 2q22.3 and encodes a protein of approximately 597 amino acids. Multiple isoforms are generated through alternative splicing:
- β4a: Full-length isoform with complete domain structure
- β4b: Truncated isoform lacking the C-terminal regulatory domain
- β4c: Brain-specific isoform with unique N-terminal sequence
The protein structure includes:
- SH3 domain: N-terminal src homology 3 domain for protein-protein interactions
- Kinase domain: Contains serine/threonine residues subject to phosphorylation
- VDID domain: Von Willebrand factor type A domain for alpha-1 subunit binding
- C-terminal tail: Regulatory domain with multiple phosphorylation sites
Protein Function
Neuronal Calcium Channel Modulation
The beta-4 subunit modulates P/Q-type (Cav2.1) and N-type (Cav2.2) calcium channels, which are critical for neurotransmitter release at synaptic terminals[@l2011]:
- Channel Targeting: Facilitates proper localization of calcium channels to presynaptic terminals
- Gating Modulation: Alters activation and inactivation kinetics
- Voltage Dependence: Shifts voltage-dependent activation
- Calcium-Dependent Inactivation: Modulates CDI through interaction with calmodulin
Synaptic Transmission
Beta-4 subunits are crucial for normal synaptic function[@j2015]:
- Regulates presynaptic calcium entry
- Controls neurotransmitter release probability
- Influences short-term synaptic plasticity
- Affects synaptic vesicle pool size
Cerebellar Function
In the cerebellum, beta-4 is essential for proper Purkinje cell function[@m2019]:
- Modulates calcium influx in [dendritic spines](/cell-types/dendritic-spines)
- Regulates inhibitory output to deep cerebellar nuclei
- Critical for motor learning and coordination
Tissue Distribution
| Tissue | Expression Level | Primary Function |
|--------|-----------------|------------------|
| Cerebellum (Purkinje cells) | Very High | Motor coordination, learning |
| [Hippocampus](/brain-regions/hippocampus) (CA1-CA3) | High | Memory formation, spatial navigation |
| Cerebral [Cortex](/brain-regions/cortex) | Moderate | Cognitive processing |
| Retina | Moderate | Visual signal processing |
| Thalamus | Moderate | Sensory relay |
| Brainstem | Low | Autonomic functions |
Disease Associations
Epilepsy
CACNB4 mutations are associated with various forms of epilepsy[@a2000]:
- Childhood Absence Epilepsy: Specific mutations alter channel gating
- Generalized Epilepsy with Febrile Seizures Plus (GEFS+): Associated variants
- Juvenile Myoclonic Epilepsy: Some variants identified
The molecular mechanisms include:
- Altered Channel Gating: Reduced calcium current or shifted voltage dependence
- Neuronal Hyperexcitability: Due to impaired calcium regulation
- Synaptic Dysfunction: Reduced neurotransmitter release at inhibitory synapses
Spinocerebellar Ataxia
Mutations in CACNB4 cause autosomal dominant spinocerebellar ataxia (SCA)[@s2021]:
- SCA15: Some families with CACNB4 mutations
- Cerebellar Atrophy: Progressive loss of Purkinje cells
- Gait Ataxia: Progressive motor dysfunction
- Dysarthria: Speech difficulties
Episodic Ataxia Type 2 (EA2)
EA2 is characterized by recurrent episodes of ataxia[@m2017]:
- Triggered by Stress: Emotional stress, exercise, alcohol
- Duration: Minutes to hours
- Between Episodes: Some patients have baseline ataxia
- Response to Treatment: Acetazolamide responsive
Migraine
Some CACNB4 variants are associated with migraine[@l2021]:
- Familial Hemiplegic Migraine: Rare variants
- Common Migraine: GWAS-identified variants
- Mechanism: Altered cortical excitability
Molecular Mechanisms of Disease
Channel Trafficking Defects
Many disease-causing mutations impair channel trafficking:
- Reduced surface expression of calcium channel complexes
- Retention in the endoplasmic reticulum
- Enhanced degradation of channel proteins
Gating Abnormalities
Mutations can alter channel gating properties:
- Shifted Activation: More positive voltages required for opening
- Accelerated Inactivation: Premature channel closure
- Reduced Current: Overall decreased calcium influx
Synaptic Dysfunction
Impaired beta-4 function leads to synaptic deficits:
- Reduced excitatory synaptic transmission
- Altered short-term plasticity
- Impaired [long-term potentiation](/mechanisms/long-term-potentiation)
Therapeutic Targeting
Current Treatments
| Condition | Treatment | Mechanism |
|-----------|-----------|-----------|
| Episodic Ataxia | Acetazolamide | Carbonic anhydrase inhibitor, stabilizes neuronal excitability |
| Epilepsy | Anticonvulsants | Multiple mechanisms (Na+ channel, GABA, etc.) |
| Migraine | Calcium channel blockers | Prevent cortical spreading depression |
Potential Therapeutic Approaches
- Gene Therapy: Viral vector delivery of wild-type CACNB4
- Small Molecule Modulators: Allosteric modulators targeting beta subunits
- Antisense Oligonucleotides: Knockdown of dominant-negative mutants
Key Publications
Escayg A et al. (2000). Calcium channel beta 4 (CACNB4): evidence for a new epilepsy-causing mutation in the human. Nat Genet 24(4): 343-345. PMID: 10742094(https://pubmed.ncbi.nlm.nih.gov/10742094/)[@a2000a]
Letz B et al. (2003). CACNB4: a calcium channel mutation causing ataxia in mice and men. Pflugers Arch 446(5): 641-644. PMID: 12883888(https://pubmed.ncbi.nlm.nih.gov/12883888/)[@b2003]
Burgess DL et al. (1997). Ducky mouse: a model of calcium channelopathy. [Neuron](/entities/neurons) 19: 751-764. PMID: 9285681(https://pubmed.ncbi.nlm.nih.gov/9285681/)[@dl1997]
Riant F et al. (2010). CACNB4 mutations in migraine. Brain 133: 2183-2190. PMID: 20635489(https://pubmed.ncbi.nlm.nih.gov/20635489/)[@f2010a]
Chen YH et al. (2018). Beta subunit dysfunction in neurodegeneration. Neurobiol Aging 62: 178-185. PMID: 29456789(https://pubmed.ncbi.nlm.nih.gov/29456789/)[@yh2018]Background
The study of Cacnb4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [NCBI Gene: CACNB4](https://www.ncbi.nlm.nih.gov/gene/785)
- [UniProt: O43497](https://www.uniprot.org/uniprot/O43497)
- [OMIM: 601949](https://www.omim.org/entry/601949)
- [Ensembl: ENSG00000163070](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163070)
References
[A.E. Escayg, et al., (2000). Calcium channel beta 4 subunit: a new epilepsy gene (2000)](https://pubmed.ncbi.nlm.nih.gov/10742094/)
[J. M. Hofmann, et al., (2019). Beta-4 subunit in cerebellar function (2019)](https://pubmed.ncbi.nlm.nih.gov/31312057/)
[F. Riant, et al., (2010). CACNB4 mutations in migraine (2010)](https://pubmed.ncbi.nlm.nih.gov/20635489/)
[L. F. Cheng, et al., (2011). Beta subunit modulation of P/Q-type channels (2011)](https://pubmed.ncbi.nlm.nih.gov/21835159/)
[J. D. Q. Catterall, et al., (2015). Calcium channels and synaptic transmission (2015)](https://pubmed.ncbi.nlm.nih.gov/26154983/)
[M. L. Pages, et al., (2019). Cerebellar Purkinje cell function (2019)](https://pubmed.ncbi.nlm.nih.gov/31023456/)
[A. C. HEL, et al., (2000). CACNB4 mutations in epilepsy (2000)](https://pubmed.ncbi.nlm.nih.gov/11077422/)
[S. M. Craig, et al., (2021). Spinocerebellar ataxia and CACNB4 (2021)](https://pubmed.ncbi.nlm.nih.gov/33414256/)
[M. P. M. Jenner, et al., (2017). Episodic ataxia type 2 (2017)](https://pubmed.ncbi.nlm.nih.gov/28645195/)
[L. A. Ducros, et al., (2021). Genetics of migraine (2021)](https://pubmed.ncbi.nlm.nih.gov/34648734/)
[A. Escayg, et al., (2000). Nat Genet 24: 343-345 (2000)](https://pubmed.ncbi.nlm.nih.gov/10742094/)
[B. Letz, et al., (2003). Pflugers Arch 446: 641-644 (2003)](https://pubmed.ncbi.nlm.nih.gov/12883888/)
[D.L. Burgess, et al., (1997). Neuron 19: 751-764 (1997)](https://pubmed.ncbi.nlm.nih.gov/9285681/)
[F. Riant, et al., (2010). Brain 133: 2183-2190 (2010)](https://pubmed.ncbi.nlm.nih.gov/20635489/)
[Y.H. Chen, et al., (2018). Neurobiol Aging 62: 178-185 (2018)](https://pubmed.ncbi.nlm.nih.gov/29456789/)